Oxygen Radical Scavengers and Myocardial Preservation during Transplantation: Role of Xanthine Oxidase
Cardiac transplantation has emerged as an important therapeutic option in the treatment of end-stage heart disease. Advances in surgical techniques in the ′50s and ′60s and myocardial preservation and immunosuppressive therapy in the ′70s have been responsible for the current success of cardiac transplantation in the ′80s. Advances in myocardial preservation used in non-transplant heart surgery have been applied to the preservation of the donor heart during its procurement, transport, and implantation. In optimal situations the generally accepted limit of hypothermic preservation of the human heart for transplantation is approximately four hours.
KeywordsInfarct Size Left Anterior Descend Xanthine Oxidase Cardioplegic Solution Xanthine Oxidase Activity
Unable to display preview. Download preview PDF.
- 2.F. Gharagozloo, F.S. Melendez, R.A. Heim, R.G. Laurence, M.S. Rosenzweig, R.J. Shemin, V.J. DiSesa, and L.H. Cohn, Superoxide dismutase and catalase preserve right and left ventricular function and compliance in the ex vivo sheep heart preserved for eight hours, Surg. Forum 37:243 (1986).Google Scholar
- 4.M. Miyamoto, G.A. Misbach, K. Tabayashi, R. Thomas, A. Luedtke, and T.D. Ivey, Myocardial function preserved by allopurinol given systemically or in cardioplegic solution, J.A.C.C. 9:88A (1987).Google Scholar
- 5.C.L. Myers, S.J. Weiss, M.M. Kirsh, B.M. Shepard, and M. Shlafer, Effects of supplementing hypothermic crystalloid cardiplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic reperfused isolated hearts, J. Thorac. Cardiovasc. Surg. 91:281 (1986).PubMedGoogle Scholar
- 6.D.K. Das, R.M. Engleman, and R. Clement, H. Otani, M.R. Parasad, and P.S. Rao, Enhancement of myocardial salvage by the free radical scavenging actions of xanthine oxidase inhibitors, abstract, Fourth International Congress on Oxygen Radicals, La Jolla, CA 7/2/87, p. 149.Google Scholar
- 9.S.W. Werns, A. Ventura, and B.R Lucchesi, Effects of allopurinol or oxypurinol on myocardial reperfusion injury, Clin. Res. 35:79A (1987).Google Scholar
- 13.J. Downey, D. Chambers, T. Miura, D. Yellon, and D. Jones, Allopurinol fails to limit infarct size in a xanthine oxidase — deficient species, Circulation 74 Suppl 11–372 (1986).Google Scholar
- 14.A.W.H Stanley, C. Prickett, T. Simpson, J. Teague, J.G. Arciniegas, T.B. Cooper, R.G. Hess, W.A.H. MacLean, S.E. Papapietro, and J. Downey, Failure to detect xanthine oxidase activity in reperfused human myocardium, Clin. Res. 35:35A (1987).Google Scholar
- 15.L. Ketai, C. Grum, C. Meyers, and M. Shlafer, Purine efflux from ischemic rabbit hearts: Lack of xanthine oxidase activity relevance to allopurinol protection, Circulation 72 III-357 (1985).Google Scholar
- 16.T. Podzuweit, W. Brawn, A. Muller, and W. Schaper, Arrhythmias and infarction in the ischemic pig heart are not mediated by xanthine oxidase-derived free oxygen radicals, Circulation 74:11–346 (1986).Google Scholar
- 17.T.A. Krenitsky, J.V. Tuttle, E.L. Cattau, and P. Wang, Comparison of the distribution and electron specification of xanthine oxidase and aldehyde oxidase, Comp. Biochem. Physiol. 49(B):687 (1974).Google Scholar
- 21.P.C. Moorhouse, M. GrootVeld, B. Halliwell, J.G. Quinlan, and J.M.C. Gutteridge, Allopurinol and oxypurinol are hydroxyl radical scavengers, F.E.B.S. 213:23 (1987).Google Scholar